H. Lundbeck A/S – OTC:HLUYY
H. Lundbeck A/S stock price today
$22
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
H. Lundbeck A/S stock price monthly change
+15.49%
month
H. Lundbeck A/S stock price quarterly change
+3.00%
quarter
H. Lundbeck A/S key metrics
Market Cap | 21.84B |
Enterprise value | 8.51B |
P/E | 28.94 |
EV/Sales | 0.66 |
EV/EBITDA | 6.73 |
Price/Sales | 2.14 |
Price/Book | 1.40 |
PEG ratio | -0.28 |
EPS | 5.63 |
Revenue | 13.86B |
EBITDA | 1.26B |
Income | 1.11B |
Revenue Q/Q | 13.00% |
Revenue Y/Y | -18.30% |
Profit margin | 9.61% |
Oper. margin | 15.78% |
Gross margin | 79.3% |
EBIT margin | 15.78% |
EBITDA margin | 9.11% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeH. Lundbeck A/S stock price history
H. Lundbeck A/S stock forecast
H. Lundbeck A/S financial statements
| Sep 2021 | 4.01B | 321M | 8% |
|---|---|---|---|
| Dec 2021 | 1B | -120M | -12% |
| Mar 2022 | 4.37B | 412M | 9.42% |
| Jun 2022 | 4.47B | 505M | 11.28% |
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2017 | 1.54% |
|---|---|
| 2018 | 4.79% |
| 2019 | 7.03% |
| 2020 | 2.63% |
| 2021 |
| Sep 2021 | 35119000000 | 17.03B | 48.51% |
|---|---|---|---|
| Dec 2021 | 16374000000 | 16.37B | 100% |
| Mar 2022 | 35071000000 | 16.62B | 47.4% |
| Jun 2022 | 37275000000 | 17.67B | 47.43% |
| Sep 2021 | 1.21B | -138M | -272M |
|---|---|---|---|
| Dec 2021 | 383M | 0 | -341M |
| Mar 2022 | -205M | -1.16B | 669M |
| Jun 2022 | 916M | -64M | -189M |
H. Lundbeck A/S alternative data
| Aug 2023 | 5,353 |
|---|---|
| Sep 2023 | 5,353 |
| Oct 2023 | 5,353 |
| Nov 2023 | 5,353 |
| Dec 2023 | 5,353 |
| Jan 2024 | 5,353 |
| Feb 2024 | 5,353 |
| Mar 2024 | 5,353 |
| Apr 2024 | 5,353 |
| May 2024 | 5,353 |
| Jun 2024 | 5,353 |
| Jul 2024 | 5,353 |
H. Lundbeck A/S other data
Monday, 14 October 2024 | ||
| Longboard Pharmaceuticals' stock soars amid Lundbeck's $2.6 billion deal to acquire the company | marketwatch.com | |
Thursday, 25 January 2024 | ||
| Lundbeck On A Better Path, But With Some Risks | Seeking Alpha | |
Monday, 17 April 2023 | ||
| Lundbeck to Present Broad Range of Data on Migraine and Brain Health at 75th Annual Meeting of the American Academy of Neurology | Business Wire | |
Tuesday, 2 August 2022 | ||
| Otsuka Pharmaceutical and Lundbeck to Present Phase 3 Data for Brexpiprazole in Patients with Alzheimer's Dementia at AAIC 2022 | Business Wire | |
Friday, 17 June 2022 | ||
| H Lundbeck AS (HLUYY) Surges 12.5%: Is This an Indication of Further Gains? | Zacks Investment Research | |
Thursday, 10 February 2022 | ||
| H. Lundbeck A/S (HLUKF) CEO Deborah Dunsire on Q4 2021 Results - Earnings Call Transcript | Seeking Alpha |
-
What's the price of H. Lundbeck A/S stock today?
One share of H. Lundbeck A/S stock can currently be purchased for approximately $22.
-
When is H. Lundbeck A/S's next earnings date?
Unfortunately, H. Lundbeck A/S's (HLUYY) next earnings date is currently unknown.
-
Does H. Lundbeck A/S pay dividends?
No, H. Lundbeck A/S does not pay dividends.
-
How much money does H. Lundbeck A/S make?
H. Lundbeck A/S has a market capitalization of 21.84B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 7.74% to 16.3B US dollars.
-
What is H. Lundbeck A/S's stock symbol?
H. Lundbeck A/S is traded on the OTC under the ticker symbol "HLUYY".
-
What is H. Lundbeck A/S's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of H. Lundbeck A/S?
Shares of H. Lundbeck A/S can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does H. Lundbeck A/S have?
As Jul 2024, H. Lundbeck A/S employs 5,353 workers.
-
When H. Lundbeck A/S went public?
H. Lundbeck A/S is publicly traded company for more then 13 years since IPO on 21 May 2012.
-
What is H. Lundbeck A/S's official website?
The official website for H. Lundbeck A/S is lundbeck.com.
-
How can i contact H. Lundbeck A/S?
H. Lundbeck A/S can be reached via phone at +45 36 30 13 11.
H. Lundbeck A/S company profile:
H. Lundbeck A/S
lundbeck.comExchange:
OTC
Full time employees:
5,353
Industry:
Drug Manufacturers—Specialty & Generic
Sector:
Healthcare
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia. It also provides Azilect for treating Parkinson's disease; Cipralex/Lexapro for depression; Ebixa to treat Alzheimer's disease; Onfi for Lennox-Gastaut syndrome; Sabril for treating epilepsy; and Xenazine for chorea associated with Huntington's disease, as well as other products. The company sells its products primarily to distributors of pharmaceuticals, pharmacies, and hospitals. It has a partnership agreement with Verantos to focus on a study to enable real-world evidence in support of migraine therapy; and collaboration with Rgenta Therapeutics, Inc. The company was founded in 1915 and is headquartered in Valby, Denmark.
Ottiliavej 9
Valby, 2500
Valby, 2500
:
ISIN: US40422M2061
:
